Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. - Wikidata - awgldk - TriplyDB

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

http://www.wikidata.org/entity/Q39173722

about

Chronic Traumatic Encephalopathy in Athletes: Progressive Tauopathy After Repetitive Head Injury Actin-binding proteins coronin-1a and IBA-1 are effective microglial markers for immunohistochemistry Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease A polymorphic gene nested within an intron of the tau gene: implications for Alzheimer's disease.Protein aggregation in the brain: the molecular basis for Alzheimer's and Parkinson's diseases Biomarkers of Alzheimer's disease Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice Pin1 in Alzheimer's disease: multiple substrates, one regulatory mechanism?Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease Using animal models to determine the significance of complement activation in Alzheimer's disease Stepping closer to treating Alzheimer's disease patients with BACE1 inhibitor drugs The amyloid hypothesis of Alzheimer's disease at 25 years Mouse Genetic Models of Human Brain Disorders Tau: The Center of a Signaling Nexus in Alzheimer's Disease Connectivity of Pathology: The Olfactory System as a Model for Network-Driven Mechanisms of Alzheimer's Disease Pathogenesis Neuronal response in Alzheimer's and Parkinson's disease: the effect of toxic proteins on intracellular pathways Alzheimer's in 3D culture: challenges and perspectives Diverse molecular targets for therapeutic strategies in Alzheimer's disease Alzheimer's therapeutics: translation of preclinical science to clinical drug development Behavioral assays with mouse models of Alzheimer's disease: practical considerations and guidelines.Alzheimer's disease, oestrogen and mitochondria: an ambiguous relationship Cross-seeding of misfolded proteins: implications for etiology and pathogenesis of protein misfolding diseases Oxidized cholesterol as the driving force behind the development of Alzheimer's disease Tau-targeted treatment strategies in Alzheimer's disease Lysosomal dysfunction promotes cleavage and neurotoxicity of tau in vivo Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?Tau physiology and pathomechanisms in frontotemporal lobar degeneration Three dimensions of the amyloid hypothesis: time, space and 'wingmen'Alzheimer's disease and prion protein The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease Down-regulation of WW domain-containing oxidoreductase induces Tau phosphorylation in vitro. A potential role in Alzheimer's disease The ubiquitin-proteasome system in Alzheimer's disease Modeling Alzheimer's disease in mouse without mutant protein overexpression: cooperative and independent effects of Aβ and tau Galantamine slows down plaque formation and behavioral decline in the 5XFAD mouse model of Alzheimer's disease.Animal models for Alzheimer's disease and frontotemporal dementia: a perspective Zebrafish models of Tauopathy Tau suppression in a neurodegenerative mouse model improves memory function Mammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis: implication for Alzheimer disease Alzheimer disease: a tale of two prions Cytoskeletal pathologies of Alzheimer disease

P2860

Q22242713-986DE925-E374-4397-A1D4-055C8ED879D1 Q24299193-C4876F4C-62A9-42BB-A3D4-A20102575882 Q24312611-8C6EF8C5-8EB0-45E1-A04C-BD713702121A Q24530700-0B835E80-FE3B-4780-AEF3-4E8587F4936D Q24650014-7A467E41-79C9-472D-93AF-FCDFA8A05AF5 Q24650667-A3D044D0-648B-464A-B8B3-6F4AACA4E528 Q24681736-2F125BEF-9195-4210-8018-C61440869E93 Q24684898-3689B0E1-3C94-48B0-AF34-F78E1115B2F5 Q24685592-977EAC33-20F2-41CA-9FFF-CA0A2D7035D1 Q24796236-8B6C9EE7-0DB3-461F-8C95-44A7E02B53F4 Q26740189-4CF8335A-5872-474C-A29C-61DFFDB6D536 Q26749528-23E1D398-824C-4D51-9541-7377A68E3766 Q26752246-E1A4CECD-A538-465F-A12F-F69124BCAC1F Q26768223-21A7CD8A-91C0-4C69-824F-27303072415A Q26773114-B0FC5438-A567-4ED8-A27C-6282DCF3A0A8 Q26779424-91B6F61B-AD97-4C67-AF6F-9CEBB9C349E8 Q26801081-CADD7210-91F1-44C0-9A17-9A9C7ED9E8EC Q26827193-CAE300FB-559C-4F98-B018-815D02588C81 Q26829267-CEA114DF-03E0-40B2-A1B6-B64241CF8013 Q26858963-C98F6DD8-C2D5-4C28-93C1-8F9B311FA3E7 Q26865759-5CE99BF2-EC7D-4D80-BB95-A177FBF0490B Q27021846-A758EDA9-2144-446C-B68B-D2D8744198FE Q27023315-74440D5E-1DE5-419B-87C1-64F1D54D91CA Q27023429-B7632B56-A40F-4113-B91A-5AA1F35BE74A Q27346877-1493B35F-9400-4AC1-84DA-B6CBCC118B3A Q28070156-8668D31C-AA23-4045-83E6-CAEB2176B720 Q28070250-CA35ACC6-FFF4-4DA1-AF27-3B4E3ECB8ADF Q28082768-7D64375A-1592-46EF-A74E-96BE0F26CCB6 Q28250275-46F5DB12-F1C1-4FF3-A32B-2D829ADD50AC Q28254943-7A3E18F2-0ABA-4D3D-AB88-68BC24BD281E Q28260248-8FCCCCA6-E278-48D9-BD67-D458B7A8B44F Q28268311-13249BAE-91A1-425E-9F4E-BF9D0E0F84C3 Q28535293-263BBDE2-3967-497C-AB1C-8F5E8B53C97A Q28540060-316782FD-3B23-4420-B8B6-183997253FCB Q28749702-FA89A0FD-0154-4EE0-84FC-DAC6A76AC80A Q28833507-09F4FE9E-F603-45A3-80AD-495D95A5DCE5 Q29615831-43A52DF0-BCC7-4575-A01B-A29F31A6A07C Q30412891-D28766D6-13DE-4B82-9965-82CC7AC9A9D0 Q30415581-01DE5A84-37B7-4B92-AEE5-46AF3EE02CA7 Q30435267-A5DB8319-A681-4DBB-866D-7883CFDC4BCF

P2860

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

http://www.wikidata.org/entity/Q39173722

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

2001年论文

@zh

2001年论文

@zh-cn

name

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

@en

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

@nl

type

label

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

@en

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

@nl

prefLabel

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

@en

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

@nl

P1433

Q39173722-2F2A9D73-2CD6-4F7A-AA88-A1528CDBF6F9

P1476

Q39173722-FE3311BD-0BF8-4216-BAB3-98DA31ADD345

P2093

Q39173722-3D55EC58-49BC-46D7-96EE-CFCC1F0AB1B9

Q39173722-4791D28A-9C6A-422D-AB21-4FC6A1109310

Q39173722-489EEF65-39DE-495C-BBEC-D9484385D590

Q39173722-4D238763-7E57-4EC4-924A-1868EFBB14F6

Q39173722-5DAD8241-9182-4097-BBDD-8A7E0C059013

Q39173722-5FDCC326-4CC4-4ACF-BDDF-BC1FB0503DA9

Q39173722-6F4FFAB8-C7B5-44A8-A0C3-BA1524568B32

Q39173722-87382E8F-D401-48D7-8EA6-EF8177C80F62

Q39173722-B74896E5-50C1-4020-8582-E2E5A76C286C

Q39173722-E9D87C23-90FE-4B4C-A9FF-A88308EFC070

P304

Q39173722-675A0FAC-46A7-422F-ACF4-AD25D80E407E

P31

Q39173722-CB1C1DAA-8197-4314-A501-E2879038D012

P356

Q39173722-362851E8-DDC6-4953-B245-B94BEADB221D

P407

Q39173722-F4D3E085-7EA4-4E04-A6E6-ED7027AC6332

P433

Q39173722-73CD5EE6-7485-42D3-93F4-B6C45D9EEEDB

P478

Q39173722-C3A15042-831B-43C9-B3F8-B69144D89372

P50

Q39173722-2D471ED5-BBE2-4FB8-BFFF-129FF5544F0D

Q39173722-F366EC08-5929-4E8A-9028-A49C16BB7D7F

P577

Q39173722-6DE67D33-2FB9-42A2-8288-CA09F62AFA1B

P5875

Q39173722-0D4AC836-1F6A-4BA5-B37A-0764CB36D116

P698

Q39173722-BBDB6A30-963D-44CB-A6D3-FB3A0C6E5478

P356

SCIENCE.1058189

P1433

P1476

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP

@en

P2093

Chisholm L

http://www.w3.org/2001/XMLSchema#string

Corral A

http://www.w3.org/2001/XMLSchema#string

Eckman C

http://www.w3.org/2001/XMLSchema#string

Hardy J

http://www.w3.org/2001/XMLSchema#string

Hutton M

http://www.w3.org/2001/XMLSchema#string

Jones G

http://www.w3.org/2001/XMLSchema#string

Lewis J

http://www.w3.org/2001/XMLSchema#string

Lin WL

http://www.w3.org/2001/XMLSchema#string

McGowan E

http://www.w3.org/2001/XMLSchema#string

Sahara N

http://www.w3.org/2001/XMLSchema#string

P304

1487-1491

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIENCE.1058189

http://www.w3.org/2001/XMLSchema#string

P407

P433

5534

http://www.w3.org/2001/XMLSchema#string

P478

293

http://www.w3.org/2001/XMLSchema#string

P50

Dennis W. Dickson

P577

2001-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11824771

http://www.w3.org/2001/XMLSchema#string

P698

11520987

http://www.w3.org/2001/XMLSchema#string